Viral infectious disease IVDs
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
01-12-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
R-Biopharm Pty Ltd
Class:
Class 2
Manufactured by:
R-Biopharm AG An der neuen Bergstrasse 17, Darmstadt, 64297 Germany
Therapeutic area:
CT355 - Viral infectious disease IVDs
Therapeutic indications:
IVDs to be used in testing to provide information about infection with or exposure to norovirus, adenovirus, rotavirus or astrovirus.
Authorization status:
A
Authorization date:
2013-08-02
